KORU Medical Systems KRMD Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Profitability | |||||
| Gross margin | 62.3%-1.1pp | 63.4%+4.8pp | 58.6%+3.5pp | 55.1%-3.5pp | |
| Operating margin | -7.2%+11.9pp | -19.2%+16.9pp | -36%+2.6pp | -38.6%-8.7pp | |
| Net margin | -6.4%+11.6pp | -18%+30.2pp | -48.2%-17.1pp | -31%-11.6pp | |
| Returns | |||||
| Return on equity | -15.6%+17.1pp | -32.6%+20.5pp | -53.2%-27.6pp | -25.5%-13.0pp | |
| Return on invested capital | -26%+27.3pp | -53.3%+11.6pp | -65%+7.5pp | -72.4%-3.3pp | |
| Efficiency | |||||
| Asset turnover | 1.5×+0.3× | 1.2×+0.4× | 0.8×+0.1× | 0.7×+0.1× | |
| Liquidity | |||||
| Current ratio | 2.4×-0.2× | 2.7×-1.9× | 4.5×+0.3× | 4.3×-3.5× | |
| Leverage | |||||
| Debt-to-equity | 0.2×0.0× | 0.2×0.0× | 0.2×+0.1× | 0.1×+0.1× | |
| Per Share | |||||
| Book value per share | $0.37+0.5% | $0.37-17.7% | $0.45-35.9% | $0.70-15.4% | |
| Valuation | |||||
| Market capitalization | $206.24M+24.9% | $176.47M+57.1% | $112.35M-30.6% | $161.98M+20.9% | |
| Price / sales | 4.8×+0.3× | 5.2×+1.3× | 3.9×-1.9× | 5.8×+0.1× | |
| Price / book | 12.2×+2.2× | 10.5×+5.0× | 5.5×+0.3× | 5.2×+1.5× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are KORU Medical Systems's profit margins?
- KORU Medical Systems (KRMD) runs a 61.9% gross margin and a -6.0% operating margin, with a -5.3% net margin.
- Where do KORU Medical Systems's ratios come from?
- Every ratio is computed from KORU Medical Systems's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
